Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0420
+0.0010 (2.44%)
Jun 26, 2026, 2:58 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $10.87 million as of June 26, 2026. Its market cap has decreased by -84.94% in one year.
Market Cap
10.87M
Enterprise Value
-1.00M
Revenue
5.92M
Ranking
n/a
PE Ratio
0.43
Stock Price
$0.04
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 10.87M, a decrease of -99.11%. That is a compound annual growth rate of -34.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 10.31M | 49.62% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 14.28M |
| Inhibitor Therapeutics | 13.38M |
| Zeo ScientifiX | 13.32M |
| BetterLife Pharma | 11.32M |
| Nymox Pharmaceutical | 11.22M |
| Brainstorm Cell Therapeutics | 10.56M |
| Curative Biotechnology | 10.13M |
| Biomind Labs | 9.31M |